SCHOTT Pharma AG & Co. KGaA (1SXP.DE)
Company Info
| ISIN | DE000A3ENQ51 |
|---|---|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
Highlights
| Market Cap | €4.56B |
|---|---|
| EPS | €0.95 |
| PE Ratio | 30.32 |
| Year Range | €26.90 - €43.23 |
| Target Price | €31.70 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of €10,000 in SCHOTT Pharma AG & Co. KGaA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 17.47% | 5.21% |
| 1 month | -0.71% | -4.30% |
| 6 months | 43.53% | 18.42% |
| 1 year | N/A | 21.82% |
| 5 years (annualized) | N/A | 11.27% |
| 10 years (annualized) | N/A | 10.33% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 7.14% | 12.78% | -2.09% | |||||||||
| 2023 | -13.40% | 4.38% | 17.48% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for SCHOTT Pharma AG & Co. KGaA (1SXP.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Not enough dataDividends
Dividend History
SCHOTT Pharma AG & Co. KGaA granted a 0.38% dividend yield in the last twelve months. The annual payout for that period amounted to €0.15 per share.
| Period | TTM |
|---|---|
| Dividend | €0.15 |
Dividend yield | 0.38% |
Monthly Dividends
The table displays the monthly dividend distributions for SCHOTT Pharma AG & Co. KGaA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | €0.15 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the SCHOTT Pharma AG & Co. KGaA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SCHOTT Pharma AG & Co. KGaA was 21.58%, occurring on Oct 31, 2023. Recovery took 63 trading sessions.
The current SCHOTT Pharma AG & Co. KGaA drawdown is 4.56%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -21.58% | Oct 12, 2023 | 14 | Oct 31, 2023 | 63 | Jan 31, 2024 | 77 |
| -9.85% | Mar 1, 2024 | 7 | Mar 11, 2024 | 7 | Mar 20, 2024 | 14 |
| -9.81% | Mar 21, 2024 | 20 | Apr 19, 2024 | — | — | — |
| -6.12% | Feb 13, 2024 | 3 | Feb 15, 2024 | 9 | Feb 28, 2024 | 12 |
| -5.18% | Oct 2, 2023 | 2 | Oct 3, 2023 | 4 | Oct 9, 2023 | 6 |
Volatility
Volatility Chart
The current SCHOTT Pharma AG & Co. KGaA volatility is 7.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |